Many stock market analysts have identified ominous signs that could indicate a looming  economic recession. How would an economic downturn...

In my previous article I discussed how stocks of small biotech companies are greatly influenced by value inflecting catalysts during...

Biotechnology has been consistently in the news as innovative scientific advancements have opened new pathways to targeting old maladies. Biotechs’...

Guest Post By Phil Kobierowski, an investor and consultant who focuses on the biotech industry.  The journey from lab to...

These three small companies are dreaming big. Each aims to make a major impact in a different disease state. If...

Many studies have shown that the number one factor in producing outsize return on investment is the original purchase price...

Wall Street Analyst Nick Ackerman writes about closed end funds and income yielding plays on Seeking Alpha. Lately Mr. Ackerman...

Up and coming Wall Street analyst Kody Kester makes the case for Amgen. Strong Cash Flow, affordable valuation, and a...

Brad J. Schmier earned his PhD in biochemistry and molecular biology from the University of Miami specializing in RNA degradation....

Every once in a while, one key understanding pushes biology forward at warp speed. Many believe that we have arrived...